Hill, William W; Lim, Emilia L EL; Weeden, Clare E CE; Lee, Claudia C; Augustine, Marcellus M; Chen, Kezhong K; Kuan, Feng-Che FC; Marongiu, Fabio F; Evans, Edward J EJ; Moore, David A DA; Rodrigues, Felipe S FS; Pich, Oriol O; Bakker, Bjorn B; Cha, Hongui H; Myers, Renelle R; van Maldegem, Febe F; Boumelha, Jesse J; Veeriah, Selvaraju S; Rowan, Andrew A; Naceur-Lombardelli, Cristina C; Karasaki, Takahiro T; Sivakumar, Monica M; De, Swapnanil S; Caswell, Deborah R DR; Nagano, Ai A; Black, James R M JRM; Martínez-Ruiz, Carlos C; Ryu, Min Hyung MH; Huff, Ryan D RD; Li, Shijia S; Favé, Marie-Julie MJ; Magness, Alastair A; Suárez-Bonnet, Alejandro A; Priestnall, Simon L SL; Lüchtenborg, Margreet M; Lavelle, Katrina K; Pethick, Joanna J; Hardy, Steven S; McRonald, Fiona E FE; Lin, Meng-Hung MH; Troccoli, Clara I CI; Ghosh, Moumita M; Miller, York E YE; Merrick, Daniel T DT; Keith, Robert L RL; Al Bakir, Maise M; Bailey, Chris C; Hill, Mark S MS; Saal, Lao H LH; Chen, Yilun Y; George, Anthony M AM; Abbosh, Christopher C; Kanu, Nnennaya N; Lee, Se-Hoon SH; McGranahan, Nicholas N; Berg, Christine D CD; Sasieni, Peter P; Houlston, Richard R; Turnbull, Clare C; Lam, Stephen S; Awadalla, Philip P; Grönroos, Eva E; Downward, Julian J; Jacks, Tyler T; Carlsten, Christopher C; Malanchi, Ilaria I; Hackshaw, Allan A; Litchfield, Kevin K; , ; DeGregori, James J; Jamal-Hanjani, Mariam M; Swanton, Charles C
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
Bmc Cancer
Ito, Masaoki M; Miyata, Yoshihiro Y; Kushitani, Kei K; Ueda, Daisuke D; Takeshima, Yukio Y; Okada, Morihito M
A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations.
Esmo Open
Villaruz, L C LC; Wang, X X; Bertino, E M EM; Gu, L L; Antonia, S J SJ; Burns, T F TF; Clarke, J J; Crawford, J J; Evans, T L TL; Friedland, D M DM; Otterson, G A GA; Ready, N E NE; Wozniak, A J AJ; Stinchcombe, T E TE
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study.
Current Oncology (Toronto, Ont.)
Hilzenrat, Roy Avraham RA; Yip, Stephen S; Melosky, Barbara B; Ho, Cheryl C; Laskin, Janessa J; Sun, Sophie S; Choi, James J JJ; McGuire, Anna L AL
Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers.
Frontiers In Endocrinology
Li, Jun J; Wei, Bing B; Feng, Junnan J; Wu, Xinxin X; Chang, Yuxi Y; Wang, Yi Y; Yang, Xiuli X; Zhang, Haiyan H; Han, Sile S; Zhang, Cuiyun C; Zheng, Jiawen J; Groen, Harry J M HJM; van den Berg, Anke A; Ma, Jie J; Li, Hongle H; Guo, Yongjun Y
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing.
Journal Of Personalized Medicine
Pujol, Nina N; Heeke, Simon S; Bontoux, Christophe C; Boutros, Jacques J; Ilié, Marius M; Hofman, Véronique V; Marquette, Charles-Hugo CH; Hofman, Paul P; Benzaquen, Jonathan J
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing.
Journal Of Pathology And Translational Medicine
Lee, Jeonghyo J; Han, Yeon Bi YB; Kwon, Hyun Jung HJ; Lee, Song Kook SK; Kim, Hyojin H; Chung, Jin-Haeng JH
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.
Frontiers In Pharmacology
Li, Hong-Shuai HS; Yang, Guang-Jian GJ; Cai, Yi Y; Li, Jun-Ling JL; Xu, Hai-Yan HY; Zhang, Tao T; Zhou, Li-Qiang LQ; Wang, Yu-Ying YY; Wang, Jin-Liang JL; Hu, Xing-Sheng XS; Yan, Xiang X; Wang, Yan Y
Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis.
Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report.
Journal Of Medical Case Reports
Van Acker, Lander L; Stevens, Dieter D; Vermaelen, Karim K; Surmont, Veerle V
Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Nature
Robichaux, Jacqulyne P JP; Le, Xiuning X; Vijayan, R S K RSK; Hicks, J Kevin JK; Heeke, Simon S; Elamin, Yasir Y YY; Lin, Heather Y HY; Udagawa, Hibiki H; Skoulidis, Ferdinandos F; Tran, Hai H; Varghese, Susan S; He, Junqin J; Zhang, Fahao F; Nilsson, Monique B MB; Hu, Lemei L; Poteete, Alissa A; Rinsurongkawong, Waree W; Zhang, Xiaoshan X; Ren, Chenghui C; Liu, Xiaoke X; Hong, Lingzhi L; Zhang, Jianjun J; Diao, Lixia L; Madison, Russell R; Schrock, Alexa B AB; Saam, Jennifer J; Raymond, Victoria V; Fang, Bingliang B; Wang, Jing J; Ha, Min Jin MJ; Cross, Jason B JB; Gray, Jhanelle E JE; Heymach, John V JV
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.
Cancers
Koopman, Bart B; Cajiao Garcia, Betzabel N BN; Kuijpers, Chantal C H J CCHJ; Damhuis, Ronald A M RAM; van der Wekken, Anthonie J AJ; Groen, Harry J M HJM; Schuuring, Ed E; Willems, Stefan M SM; van Kempen, Léon C LC
Mutation Spectrum of EGFR From 21,324 Chinese Patients With Non-Small Cell Lung Cancer (NSCLC) Successfully Tested by Multiple Methods in a CAP-Accredited Laboratory.
A Lung Adenocarcinoma Patient With a Rare EGFR E709_T710delinsD Mutation Showed a Good Response to Afatinib Treatment: A Case Report and Literature Review.
Frontiers In Oncology
Wei, Yu Y; Cui, Yueli Y; Guo, Yao Y; Li, Lei L; Zeng, Liang L